JPMorgan analyst Rachel Vatnsdal downgraded Akoya Biosciences Inc (NASDAQ: AKYA) from Overweight to Neutral.The analyst comments: "This afternoon, Akoya (AKYA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE